Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
This study has been completed.
Study NCT00063297 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on June 25, 2003. Last Updated on August 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers